December 20, 2005 - Taking 1,000 international units (IU) of vitamin D 3 daily appears to lower an individual's risk of developing colorectal cancer by 50 percent, according to an extensive literature review led by cancer prevention specialists at the Moores Cancer Center at the University of California, San Diego (UCSD) Medical Center. The researchers call for prompt public health action to increase intake of vitamin D 3 as an inexpensive, non-toxic prevention for a disease that claims 56,000 U.S. lives each year.
Map of Colon Cancer, USA, 1970-1994 from SUNARC (Sunlight, Nutrition And Health Research Center), San Francisco, CA
A typical over the counter multivitamin supplement for adults contains 400 international units (IU), listed as one hundred percent of the recommended DV (daily value) for this vitamin. National Institutes of Health dietary supplements recommends 400 to 600 IU for older adults. Is this enough?
"Studies over the last 25 years have shown that vitamin D is associated with preventing colon cancer, but we haven't known how much is needed to produce a benefit," said Edward D. Gorham, assistant adjunct professor of Family and Preventive Medicine at UCSD School of Medicine and a cancer epidemiologist affiliated with the Moores UCSD Cancer Center.
"This paper establishes the target level of vitamin D that could reduce the incidence of colorectal cancer by half," Gorham said.
Intake of 1,000 IU/day of vitamin D, half the safe upper intake established by the National Academy of Sciences, was associated with 50 percent lower risk (of colorectal cancer).
Individuals with vitamin D blood levels of 33 nanograms per milliliter, generated through modest sunlight exposure, also had a 50 percent lower incidence of colorectal cancer.
Gorham adds that this does not prove a causal relationship and further studies need to be done.
Other chemopreventive agents are proving to be effective.
Researchers at M. D. Anderson, a leading US cancer hopsital, have found that:
"Interventional studies, or clinical trials, are needed to further define the relationship between vitamin D and colon cancer," he said, "but such studies could take more than 20 years to complete. Since the safety of daily intake of vitamin D 3 in the recommended range has been thoroughly assessed and confirmed by the National Academy of Sciences, and the benefits found so far in observational studies are considerable, expanded use of vitamin D as a public health measure should not be delayed."
The findings are based upon an extensive systematic review of scientific papers on the relationship of blood serum levels or oral intake of vitamin D with risk of colorectal cancer published worldwide between January 1966 and December 2004. Forty four articles were identified; 18 articles met the study's criteria for inclusion. A majority (10) of the studies found that inadequate vitamin D status was significantly associated with higher risk of colorectal cancer. The other eight studies ranged from a borderline association to no association.
This complex analysis of virtually every scientific paper written on the subject, called a systematic review, paints a clearer picture than any single study and is recognized by scientists as an important tool for establishing a consensus of findings. For example, some studies, particularly those conducted in Scandinavian countries, did not find an effect.
"When we looked at the Scandinavian studies in the context of all of the studies, we realized there may be reasons specific to those countries that can explain the anomaly," Gorham said. "In Scandinavian countries, vitamin D comes largely from fish. Most of their fish is smoked, salted or preserved. These are carcinogenic, so the carcinogens could offset the benefit."
Gorham said that while this study looked at all forms of vitamin D  intake through diet or supplements, and photosynthesis through modest sun exposure  as a practical matter, most people will most easily achieve the target levels by taking supplements.
"Many people are deficient in vitamin D. A glass of milk, for example, has only 100 IU. Other foods, such as orange juice, yogurt and cheese, are now beginning to be fortified, but you have to work fairly hard to reach 1,000 IU a day," he explained. "Sun exposure has its own concerns and limitations. We recommend no more than 15 minutes of exposure daily over 40 percent of the body, other than the face, which should be protected from the sun. Dark-skinned people, however, may need more exposure to produce adequate amounts of vitamin D, and some fair-skinned people shouldn't get any vitamin D from the sun. The easiest and most reliable way of getting the appropriate amount is from a daily supplement."
The authors make several recommendations for action. They call for the U.S. federal government to:
Some 145,000 new cases of colorectal cancer are diagnosed each year in the U.S. This new review suggests that approximately 72,500 new cases and 28,000 deaths could be prevented with appropriate intake of vitamin D.
The researchers ran a cost/benefit analysis and concluded: "Preventing approximately half of colorectal cancer incidence by a program that would ensure vitamin D adequacy could save an estimated $20 billion per year. Annual supplementation of all Americans with 1,000 IU per day of vitamin D 3 would cost approximately $5 billion. Although further economic investigation would be desirable, a gross estimate of the annual return on investment, considering the cost of supplementation, would be $15 billion per year, amounting to a nearly 40 percent per annum return on investment."
Vitamin D , NSAIDS provide double whammy against prostate cancer
http://www.psa-rising.com/med/chemo/vitD_NSAIDs05.html
Vitamin D , Taxotere Combination Promising For Advanced Prostate Cancer
http://www.psa-rising.com/med/chemo/vitD_D101.html
Tumeric (Curcumin) as Cancer Fighter
http://www.psa-rising.com/eatingwell/turmeric.htm
FDA says Celebrex Heart Risk More Than Tripled
http://www.psa-rising.com/med/recurrent/celebrex_heart-fda04.html
Celebrex , Cancer Patients and the Vioxx Cover-Up
http://www.psa-rising.com/upfront/COX2_1011.04.html
FDA Advised to Let Celebrex Stay on Market, Call for Warning Labels
http://www.psa-rising.com/med/recurrent/celebrex_nofdaban05.html
Sources and Links:
Vitamin D and prevention of colorectal cancer.
Journal of Steroid Biochemistry and Molecular Biology, 2005 Oct;97(1-2):179-94. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF.The researchers are affiliated with these institutions:
Naval Health Research Center, San Diego, CA;
University of California, San Diego, School of Medicine, Department of Family and Preventive Medicine, La Jolla, CA;
SUNARC (Sunlight, Nutrition And Health Research Center), San Francisco, CA;
Strang Cancer Prevention Center, New York, NY
Susan Lehman Cullman Laboratory for Cancer Research, Rutgers, The State University of New Jersey, Piscataway, and The Cancer Institute of New Jersey, New Brunswick, NJ
Harvard School of Public Health, Departments of Nutrition and Epidemiology, Boston, MA
Vitamin D Laboratory, Section of Endocrinology, Nutrition and Diabetes, Department of Medicine, Boston University School of Medicine, Boston, MASummary:
"BACKGROUND: Inadequate photosynthesis or oral intake of Vitamin D are associated with high incidence rates of colorectal cancer, but the dose-response relationship has not been adequately studied.
METHODS: Dose-response gradients from observational studies of Vitamin D intake and serum 25-hydroxyvitamin D were plotted as trend lines. The point on each linear trend line corresponding to an odds ratio of 0.50 provided the prediagnostic Vitamin D intake or 25-hydroxyvitamin D concentration associated with 50% lower risk compared to <100IU/day Vitamin D or <13ng/ml serum 25-hydroxyvitamin D. Medians of these values were determined.
RESULTS: Overall, individuals with >or=1000IU/day oral Vitamin D (p<0.0001) or >or=33ng/ml (82nmol/l) serum 25-hydroxyvitamin D (p<0.01) had 50% lower incidence of colorectal cancer compared to reference values.
CONCLUSIONS: Intake of 1000 IU/day of Vitamin D, half the safe upper intake established by the National Academy of Sciences, was associated with 50% lower risk. Serum 25-hydroxyvitamin D of 33ng/ml, which is known to be safe, also was associated with 50% lower risk. Prompt public health action is needed to increase intake of Vitamin D(3) to 1000IU/day, and to raise 25-hydroxyvitamin D by encouraging a modest duration of sunlight exposure. "
This page uses information from UCSD and MD Anderson press offices, edited by J. Strax, last updated December 22, 2005.
Information on this website is not intended as medical advice nor to be taken as such. Consult qualified physicians specializing in the treatment of prostate cancer. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained on this website.
About Us | Site Archive | Content Policy/Disclaimer | Privacy Policy
UK biologists extract prostate tumor stem cells Dec 2005
Coping With Side effects of Taxotere chemo Dec 2005
Estrogen's role in cerebral blood vessel health Aug 2005
Zometa® Reduces Bone Loss From Hormonal Blockade in Prostate Cancer Patients. Dec 5, 2005
Soy derivative, Phenoxodiol, Slows Advance Prostate Cancer - No Side Effects November 17, 2005
We subscribe to the HONcode principles.
Verify here.
I Can Cope program for cancer patients and their families